Loading
Life sciences · Journal article
Frontiers in Adolescent Medicine · October 12, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background Improved survival in low- and middle-income countries is generating a rapidly expanding population of childhood cancer survivors (CCS) who will transition to adult care. In India, the capacity and geographic distribution of long-term survivorship care remain poorly characterized. Methods We synthesized survivorship data from three tertiary pediatric oncology centres in North India. Transition-eligible survivors were those diagnosed before age 18 years, who completed cancer-directed therapy between January 2016 and December 2025 and had attained age >18 years by December 2025. We quantified the transition-eligible cohort, projected the transition burden through 2030, mapped adolescent and young adult (AYA) survivors by geographic distance from their treating centre, and risk-stratified survivors for survivorship care planning as per published diagnosis and exposure based criteria. Results Among 3,060 survivors, 398 (13.0%) were transition-eligible; 288 (72.4%) were male. Lymphomas (34.1%), solid tumors (29.1%), and acute lymphoblastic leukemia (27.8%) were the predominant diagnoses. The transition-eligible cohort is projected to increase to 1,071 by 2030 (+169.1%). Approximately 58% lived >50 km from their treating centre. Overall, 387 (97.2%) were classified as moderate (44.9%) or high risk (52.3%). Transition processes were absent (56%) or informal (33%); barriers included perceived lack of need (78%), unawareness of late effects (67%) and farther distance from treating centre (56%). Conclusion This study estimates that the transition-eligible CCS population is projected to nearly triple by 2030 and is predominantly composed of moderate- and high-risk survivors. A risk-stratified, geographically distributed survivorship model incorporating tele-support and shared care closer to home is urgently required.